Skip to main content
Clinical Trials/NCT03543241
NCT03543241CompletedNot Applicable

MyoStrain CMR Testing of Ischemia With Low Levels of Stress

Myocardial Solutions1 site in 1 country13 target enrollmentStarted: November 8, 2017Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
13
Locations
1
Primary Endpoint
Sensitivity of Ischemic CAD Detection

Study Overview

Brief Summary

This prospective, observational study evaluates the accuracy of stress testing with the MyoStrain SENC CMR Imaging System to detect myocardial ischemia and viability in patients with suspected coronary artery disease using low levels of stress.

Detailed Description

This prospective, single center study evaluates the MyoStrain SENC CMR Imaging System for the detection of myocardial ischemia and viability during conventional Cardiac Magnetic Resonance (CMR) wall motion stress testing. Patients with known or suspected coronary artery disease and scheduled for cardiac catheterization will be consented for inclusion in the study and evaluated during stress testing with low dose Dobutamine as the stressor agent. Data obtained with the MyoStrain SENC CMR Imaging System will be for observational purposes and will not be used to alter patient management.

Study Design

Study Type
Observational
Observational Model
Case Only
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to 80 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Known or suspected Coronary Artery Disease
  • Symptoms potentially due to CAD; stable angina
  • Positive imaging stress test or negative stress test but typical angina or anginal equivalent
  • Negative Troponin with unstable angina
  • Invasive coronary angiography planned within 3 months of CMR
  • Provided written consent

Exclusion Criteria

  • Pregnancy
  • Contraindication to Magnetic Resonance Imaging
  • Prior allergy to Dobutamine
  • Severe aortic stenosis
  • Hypertrophic Cardiomyopathy
  • Clinically significant Ventricular Tachycardia that would prohibit Dobutamine administration

Outcomes

Primary Outcomes

Sensitivity of Ischemic CAD Detection

Time Frame: Up to coronary angiography within 1 month of standard CMR stress testing

Sensitivity of correctly identifying ischemic coronary artery disease based on cardiac catheterization results using low dose Dobutamine stress testing with MyoStrain software

Secondary Outcomes

  • Specificity of Ischemic CAD Detection(Up to coronary angiography within 1 month of standard CMR stress testing)

Investigators

Sponsor
Myocardial Solutions
Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials

MyoStrain CMR Testing of Ischemia With Low... | Clinical Trial